Comparison of Natural and Dumon airway stents for the management of benign tracheobronchial stenoses

Authors: RYU, YonJu1; KIM, Hojoong; YU, Chang-Min2; CHOI, JaeChul2; KWON, YongSoo2; KIM, Jhingook3; SUH, SooWon4

Source: Respirology, Volume 11, Number 6, November 2006 , pp. 748-754(7)

Publisher: Wiley-Blackwell

Buy & download fulltext article:

OR

Price: $48.00 plus tax (Refund Policy)

Abstract:

Comparison of Natural and Dumon airway stents for the management of benign tracheobronchial stenoses

RYU YJ, KIM H, YU C-M, CHOI JC, KWON YS, KIM J, SUH SW. Respirology 2006; 11: 748-754 Objective and background: 

To investigate the utility and safety of the `Natural stent', a newly designed silicone airway stent, the authors compared clinical outcomes and complications in patients who underwent silicone airway stenting for the management of benign airway stenosis. Methods: 

The medical records of 94 patients requiring the placement of 100 airway stents (43 Dumon and 57 Natural) were retrospectively reviewed in a tertiary referral hospital. Results: 

Post-tuberculous stenosis was the leading indication for airway stenting (74%), followed by post-intubation stenosis (21%). After intervention, dyspnoea improved in patients who underwent Dumon (90%) and Natural (86%) stenting. After stabilizing dyspnoea, stents could be successfully removed in half of the patients who underwent Dumon (54%) or Natural (49%) stenting. During a 42-month follow-up period, complication rates were similar in patients who underwent Dumon or Natural stenting. Conclusion: 

Natural airway stent was as effective and safe as Dumon stent for the management of benign tracheobronchial stenoses.

Keywords: airway obstruction; bronchoscopy; intervention; tracheal stenosis

Document Type: Research article

DOI: http://dx.doi.org/10.1111/j.1440-1843.2006.00955.x

Affiliations: 1: Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Dongdaemun Hospital, College of Medicine, Ewha Womans University, 2: Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, and Departments of 3: Thoracic and Cardiovascular Surgery and 4: Biomedical Engineering, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea

Publication date: 2006-11-01

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page